-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In response to the current global spread of the new crown epidemic, the SARS-CoV-2 mRNA vaccine represented by Pfizer has been widely used abroad .
In response to the current global spread of the new crown epidemic, the SARS-CoV-2 mRNA vaccine represented by Pfizer has been widely used abroad .
2020 December 16 to April 15, 2021 inoculated two needles new crown mRNA vaccine in 1377 RMD patients completed a questionnaire, the contents in detail, including the per -pin partial 7 days after vaccination (D1, D2) And systemic reactions , and the onset of RMD within 1 month afterD2 .
The results are as follows: 11% of patients had an acute attack requiring treatment ; there were no serious attacks .
The results are as follows: 11% of patients had an acute attack requiring treatment ; there were no serious attacks .
It can be seen that it is not common for RMD patients to have seizures after being vaccinated with the new crown mRNA vaccine
Original source: Original source:
Caoilfhionn M.
Caoilfhionn M.
Leave a message here